Fig. 3

a, Comparison of treatment-free interval (days) between patients with TCs expressing high PD-L1 (n = 17) vs. low PD-L1 (n = 16), those with TICs expressing high PD-L1 (n = 13) vs. low PD-L1 (n = 20), those with PD-1⁺ TICs of high density (n = 24) vs. low density (n = 9), those with TCs expressing high VEGF (n = 27) vs. low VEGF (n = 6), those with CD4⁺ TICs of high density (n = 13) vs. low density (n = 20), those with CD8⁺ TICs of high density (n = 5) vs. low density (n = 28), and those with CD68⁺ TICs of high density (n = 24) vs. low density (n = 9). b, Comparison between patients with MSS tumor (n = 173) vs. MSI tumor (n = 48) of IHC scores of PD-L1 expression in TCs, IHC scores of PD-L1 expression in TICs, density of PD-1⁺ TICs, IHC scores of VEGF expression in TCs, density of CD4⁺ TICs, density of CD8⁺ TICs, and density of CD68⁺ TICs